Rapid Micro Biosystems Inc. (RPID) is scheduled to release fourth quarter and full year 2024 financial results before the market opens tomorrow (Feb.28, 2025).
This life sciences technology company manufactures and sells the "Growth Direct system" and related proprietary consumables, and value-added services to enable rapid microbial quality control, or MQC, testing in the manufacture of biologics and cell and gene therapies, vaccines, sterile injectables, and other healthcare products.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.